Cannabis Law Report

OCTOBER 29, 2021

(NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The Company is preparing an INDA submission to the FDA for a Phase 2/3 trial for the use of IGC-AD1 to address symptoms associated with Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Cannigma

MAY 13, 2022

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. When this system alone can’t manage the pain, outside cannabinoids like THC can help. THC has several properties that make it effective at treating pain: Reducing inflammation Reducing pain Preventing/reducing vomiting.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

Cannabis Law Report

SEPTEMBER 22, 2021

Accelerated timelines to clinical trials and expansion of drug development pipeline. Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

OCTOBER 15, 2021

Xebra’s 125,619,492 issued and outstanding common shares will commence trading at market open on Monday, October 18, 2021 under the ticker symbol “ XBRA “. Planting of the first trial crop is expected to commence in December 2021 , which will be harvested and submitted to the Dutch government in March 2022. THE NETHERLANDS.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

Cannabis Law Report

FEBRUARY 3, 2022

million in 2021, and is projected to reach USD 176,005.5 million by 2030 at a CAGR of 23.9%, 2021-2030. Based on the compound, the market is segmented into tetrahydrocannabinol (THC)-dominant, cannabidiol (CBD)-dominant, and balanced THC and CBD. 2564 (2021). Clinical Trials of Cannabis Are Still on Going.

Indica 52

Indica Oil Legalization Research and Development 52

Cannabis Law Report

NOVEMBER 4, 2021

Litigation against the DEA and Department of Justice that Matthew Zorn and I brought on behalf of Dr. Sisley and Scottsdale Research Institute (SRI) ended that NIDA monopoly in May 2021. delta-9 THC, meaning they aren’t a controlled substance under federal law. Use the plants for their own studies and/or FDA clinical trials.

DEA 52

DEA Clinical Trials Advocacy Legislation 52

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. Dr. Eric Hollander, the Director of the Autism and Obsessive Compulsive Spectrum Program and Anxiety and Depression Program at Montefiore Hospital, is leading the clinical trial.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

The Cannigma

MAY 17, 2022

The best strains for creativity are Type II, with a balance of THC and CBD and a terpene profile that includes pinene, linalool, and beta-caryophyllene. On the other hand, a 2015 study found that large doses of THC can actually make you less creative. Type I – High THC. How cannabis can boost creativity.

Terpenes 128

Terpenes Strains THC Oil 128

Veriheal

MAY 25, 2023

million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 75.52% to $3871.44 Ketamine works differently than traditionally prescribed antidepressant medications, which normally influence serotonin levels ( much like tetrahydrocannabinol (THC) does ) or other neurotransmitters in the brain. million by 2027.

Medicine 98

Medicine Blood Pressure Therapy Clinical Trials 98

Cannabis Law Report

JUNE 17, 2021

VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — Brains Bioceutical Corp. Brains is one of a few companies in the world producing CBD as an API for pharmaceutical applications, research, development, and clinical trials. CBD and zero Tetrahydrocannabinol (THC).

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

The Cannigma

AUGUST 14, 2022

The best weed strains to help you focus have a balance of CBD and THC, are energizing and stress-relieving, and have a terpene profile that includes pinene, linalool, or beta-caryophyllene. You don’t necessarily want a strain that is entirely CBD or THC , but ideally a combination of the two. Type I – High THC.

Terpenes 118

Terpenes Strains THC Oil 118

Cannabis Law Report

JULY 8, 2021

The Company expects to finalize the agreement with the research institute and commence studies by Fall 2021. cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. produced, THC-free 1 CBD products. Sibyl Swift, VP, Scientific & Regulatory Affairs.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

The Cannigma

JUNE 23, 2022

CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. Often CBGA is presumed to interact with CB1 and CB2 receptors, more similar to THC and or CBG, but emerging science suggests this is likely not the case. What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Healer

DECEMBER 17, 2021

November 5, 2021. Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. The more accurate concern with warfarin is its interaction with THC because both warfarin and THC are metabolized by the liver enzyme CYP2C9.

CBD 98

CBD THC Conditions Medicine 98

Cannabis Law Report

AUGUST 19, 2021

Such products will generate sales of £690 million ($856 million, 811 million euros) in 2021, according to the Association for the Cannabinoid Industry (ACI). Such products are stripped of psychoactive tetrahydrocannabinol or THC molecules, which are found in recreational cannabis that remains illegal in Britain.

Cannabinoids 105

Cannabinoids Seed-To-Sale Clinical Trials CBD 105

Canna Care Docs

DECEMBER 16, 2020

The New Year is fast approaching, and if you’re not feeling entirely hopeful about 2021, you’re certainly not alone. Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Enough is enough. Chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

SEPTEMBER 8, 2021

The partnership is reflected in the terms of the Binding Heads of Agreement between the Epsilon, THC Pharma (the Epsilon’s wholly owned subsidiary, and owner of the Southport Facility), Valens, and Valens Australia Pty Ltd (Valens’ wholly owned subsidiary) (the “ Agreement “).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JULY 14, 2021

(“ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. ImmunoFlex has submitted non-provisional ( USA ) and PCT (international) patent applications based on the research carried out by ImmunoFlex in 2020 and 2021.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

AUGUST 2, 2021

CBD is much more subtle in its effects and quite benign compared to THC. Anonymized aggregate results will be released in October 2021. Radicle Science disrupts the traditional clinical trial model by combining the reach of a market research company, the scientific rigor of a research university, and the agility of a tech company.

CBD 105

CBD Data Sleep Clinical Trials 105

Healer

MARCH 26, 2021

March 19, 2021. Since 2015, the National Institutes of Health’s National Institute on Drug Abuse has funded research surrounding the therapeutic benefits of tetrahydrocannabinol (THC) and cannabidiol (CBD) for the treatment of pain as an alternative to opioids, addiction and other disorders. Others aren’t so sure.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Healer

DECEMBER 17, 2021

November 5, 2021. Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. The more accurate concern with warfarin is its interaction with THC because both warfarin and THC are metabolized by the liver enzyme CYP2C9.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

JUNE 4, 2021

With Delta 8, one is not going to have an anxious or paranoia episode as can be common for newcomers to marijuana forms of cannabis – especially with high concentration of THC that is readily available today. The legal cannabis industry is expected to exceed $40 billion in 2021 and CBD sales should reach $5 billion.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Veriheal

AUGUST 31, 2020

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Previously a Schedule I substance, hemp was reclassified; hemp has extremely low levels of THC (less than 0.3%).

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

DECEMBER 12, 2022

Just as THCA in cannabis flower needs to be decarboxylated into the active compound THC, psilocybin is not active until it undergoes a chemical reaction. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. As such, there have been numerous clinical trials using ketamine.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. In adults, cannabinoids-related adverse events were previously associated with physiological reactions, including hyperthermia, rhabdomyolysis, increased appetite, and hypoglycemia, mostly in exposure to THC 14 , 15 , 16. Stolar & Ilan Matok.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

SEPTEMBER 21, 2021

In 2016, she helped cofound “Whoopi & Maya,” a business that made wellness products for women, including THC and CBD-rich topicals and tinctures. Particularly when I had to wean myself off morphine and I used cannabis which is not going to kill you as opiates can,” Newton John said. 7) Morgan Freeman.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.)

CBD 144

CBD Seed-To-Sale Food Access 144

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects.

Terpenes 132

Terpenes Strains THC Treatment 132

Project CBD

OCTOBER 26, 2023

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

OCTOBER 22, 2021

The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” report provides comprehensive insights for about 25+ companies and 50+ pipeline drugs in Medical Marijuana – Cannabidiol pipeline landscape.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

NOVEMBER 12, 2021

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction, today announced financial results for the first quarter of its fiscal year ending June 30, 2022 and reported recent business highlights. million as of September 30, 2021.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

SEPTEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. Global Legal Cannabis Industry: Number of Clinical Trials, By Region. The global legal cannabis market size is expected to reach USD 91.5 over the forecast period.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

OCTOBER 18, 2021

DUBLIN–(BUSINESS WIRE)–The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. BX-1: Bionorica SE.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Canna Law Blog

NOVEMBER 6, 2021

Instead, qualifying evidence may come from adequate and well-controlled clinical trials. Phase I trials should be sufficient, and many have been completed using psilocybin. Rescheduling can help solve this problem by promoting larger trials. Regardless, unblinding is likely less of a problem than critics claim.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? Seventy-six mostly male veterans between the ages of 24 and 77 completed the Phase 1 trial. Co-author Dr Sue Sisley says that the results are promising.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. A 2010 study found that consuming alcohol “slightly prolonged” the half-life of THC in the blood.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128